Effectiveness of the BNT162b2 mRNA COVID-19 vaccine in pregnancy.

Author(s): Dagan N, Barda N, Biron-Shental T, Makov-Assif M, Key C, Kohane IS, Hernán MA, Lipsitch M, Hernández-Díaz S, Reis BY, Balicer RDJournal: Nat MedPMID: 34493859 September 2021
To evaluate the effectiveness of the BNT162b2 messenger RNA vaccine in pregnant women, we conducted an observational cohort study of…

Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting.

Author(s): Barda N, Dagan N, Ben-Shlomo Y, Kepten E, Waxman J, Ohana R, Hernán MA, Lipsitch M, Kohane I, Netzer D, Reis BY, Balicer RDJournal: N Engl J MedPMID: 34432976 August 2021
Preapproval trials showed that messenger RNA (mRNA)-based vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) had a good safety…

Near real-time surveillance of the SARS-CoV-2 epidemic with incomplete data.

Author(s): De Salazar PM, Lu F, Hay JA, Gomez-Barroso D, Fernandez-Navarro P, Martínez E, Astray-Mochales J, Amillategui R, Garcia-Fulgueiras A, Chirlaque MD, Sanchez-Migallon A, Larrauri A, Sierra MJ, Lipsitch M, Simon F, Santillana M, Hernán MAJournal: medRxivPMID: 33532788 January 2021
Designing public health responses to outbreaks requires close monitoring of population-level health indicators in real-time. Thus, an accurate estimation of…

Infective endocarditis and cancer in the elderly.

Author(s): García-Albéniz X, Hsu J, Lipsitch M, Logan RW, Hernández-Díaz S, Hernán MAJournal: Eur J EpidemiolPMID: 26683995 January 2016
Little is known about the magnitude of the association between infective endocarditis and cancer, and about the natural history of…